Variables | n (%) | mediana(IQR) |
---|---|---|
Age | 69.0 (65.0 – 73.0) | |
Place of residence | ||
Urban | 56 (70.9) | |
Rural | 23 (29.1) | |
Initial Clinical presentation | ||
LUTS | 69 (87.3) | |
bNSAID use | 51 (64.6) | |
Anaemia (<10 g/dL) | 25 (31.6) | |
PADT received | ||
Orchiectomy | 65(82.3) | |
LH-RH analogues | 14 (17.7) | |
PSA kinetics | ||
Pre-treatment PSA(ng/mL) | 94.0 (50.0 – 124.0) | |
PSA nadir (ng/mL) | 4.0 (1.0 – 9.0) | |
PSA decline | ||
≥ 90% | 60 (75.9) | |
< 90% | 19 (24.1) | |
Biopsy Gleason score | ||
3 + 3 | 24 (30.4) | |
3 + 4 | 10 (12.7) | |
4 + 3 | 20 (25.3) | |
≥ 8 | 25 (31.7) |